News

Venmax Drugs & Pharmaceuticals Limited will hold a board meeting on August 31, 2026, at 4:30 P.M. to discuss the notice, directors` report, and annual report for the financial year 2025-26, as well as to decide on the date, time, and venue of the 37th Annual General Meeting.

Net profit of Venmax Drugs & Pharmaceuticals rose 200.00% to Rs 0.12 crore in the quarter ended June 2026 as against Rs 0.04 crore during the previous quarter ended June 2025. Sales rose 104.96% to Rs 2.48 crore in the quarter ended June 2026 as against Rs 1.21 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales2.481.21 105 OPM %4.843.31 - PBDT0.120.04 200 PBT0.120.04 200 NP0.120.04 200 Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2026.

Net profit of Venmax Drugs & Pharmaceuticals declined 85.90% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 0.78 crore during the previous quarter ended March 2025. Sales rose 1093.94% to Rs 3.94 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 0.25 crore in the year ended March 2026 as against net loss of Rs 0.01 crore during the previous year ended March 2025. Sales rose 890.12% to Rs 8.02 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales3.940.33 1094 8.020.81 890 OPM %0.51-72.73 -1.50-129.63 - PBDT0.110.78 -86 0.280 0 PBT0.110.78 -86 0.28-0.01 LP NP0.110.78 -86 0.25-0.01 LP Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 May 2026.